Distinct transcription profiles of primary and secondary glioblastoma subgroups

Cancer Research

Volumn 66, Issue 1, 2006, Pages 159-167

  Tso, Cho Lea ^a   Freije, William A ^a   Day, Allen ^a   Chen, Zugen ^a   Merriman, Barry ^a   Perlina, Ally ^a   Lee, Yohan ^a   Dia, Ederlyn Q ^a   Yoshimoto, Koji ^a   Mischel, Paul S ^a   Liau, Linda M ^a   Cloughesy, Timothy F ^a   Nelson, Stanley F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN TUMOR; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CARCINOGENESIS; CELL CYCLE; CLINICAL CLASSIFICATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GLIA CELL; GLIOBLASTOMA; GLIOBLASTOMA ASSOCIATED GENE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

APOPTOSIS; ASTROCYTOMA; BRAIN NEOPLASMS; CELL CYCLE; CELL GROWTH PROCESSES; GENE EXPRESSION PROFILING; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MESODERM; STROMAL CELLS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 31544467538     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0077     Document Type: Article

References (47)

1. Shackney SE, Shankey TV. Common patterns of genetic evolution in human solid tumors [review]. Cytometry 1997;29:1-27.
2. Cai WW, Mao JH, Chow CW, et al. Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays. Nat Biotechnol 2002;20:393-6.
3. Zhang LH, Qin LX, Ma ZC, et al. Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis. Cancer Res Clin Oncol 2003;129:279-86.
4. Smith CA, Pollice AA, Gu LP, et al. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas. Clin Cancer Res 2000;6:112-26.
5. Morales CP, Souza RF, Spechler SJ. The hallmarks of cancer. Cell 2000;100:57-70.
6. Scott JN, Rewcastle NB, Brasher PM, et al. Long-term glioblastoma multiforme survivors: a population-based study. Can J Neurol Sci 1998;25:197-201.
7. Prat DJ, Van Meir EG. Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma [review]. Lab Invest 2004;84:397-405.
8. Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis [review]. Neuro-oncol 1999;1:44-51.
9. Maruno M, Ninomiya H, Ghulam Muhammad AK, et al. Whole-genome analysis of human astrocytic tumors by comparative genomic hybridization. Brain Tumor Pathol 2000;7:21-7.
10. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system [review]. J Neuropathol Exp Neurol 2002;61: 215-25.
11. Freije WA, Castro-Vargas FE, Fang Z, et al. Gene expression profiling of gliomas strongly predicts survival. Cancer Res 2004;64:6503-10.
12. Shai R, Shi T, Kremen TJ, et al. Gene expression profiling identifies molecular subtypes of gliomas. Oncogene 2003;22:4918-23.
13. Choe G, Horvath S, Cloughesy TF, et al. Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res 2003;63: 2742-6.
14. To CT, Tsao MS. The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers [review]. Oncol Rep 1998;5:1013-24.
15. Cuttitta F, Pio R, Garayoa M, et al. Adrenomedullin functions as an important tumor survival factor in human carcinogenesis [review]. Microsc Res Tech 2002; 57:110-9.
16. Maulik G, Madhiwala P, Brooks S, et al. Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer. J Cell Mol Med 2002;6:539-53.
17. Wang X, DeFrances MC, Dai Y, et al. Mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol Cell 2002;9:411-21.
18. Miyashita K, Itoh H, Sawada N, et al. Adrenomedullin provokes endothelial Akt activation and promotes vascular regeneration both in vitro and in vivo. FEBS Lett 2003;544:86-92.
19. Terman BI, Stoletov KV. VEGF and tumor angiogenesis. Einstein Quart J Biol Med 2001;18:59-66.
20. Wang X, Kiyokawa H, Dennewitz MB, Costa RH. The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc Natl Acad Sci U S A 2002;99: 16881-6.
21. Raisanen SR, Lehenkari P, Tasanen M, et al. Carbonic anhydrase III protects cells from hydrogen peroxide-induced apoptosis. FASEB J 1999;13:513-22.
22. Mankoo BS, Collins NS, Ashby P, et al. Mox2 is a component of the genetic hierarchy controlling limb muscle development Nature 1999;400:69-73.
23. A, Artan S, Oner U, et al. The importance of genomic copy number changes in the prognosis of glioblastoma multiforme. Neurosurg Rev 2004;27:58-64.
24. Li L, Ren CH, Tahir SA, Ren C, Thompson TC. Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A. Mol Cell Biol 2003;23:9389-404.
25. Feldkamp MM, Lala P, Lau N, Roncari L, Guha A. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens. Neurosurgery 1999;45:1442-53.
26. Xiao GH, Jeffers M, Bellacosa A, et al. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc Natl Acad Sci U S A 2001;9:247-52.
27. Zhang Q, Wu Y, Chau CH, et al. Crosstalk of hypoxia-mediated signaling pathways in upregulating plasminogen activator inhibitor-1 expression in keloid fibroblasts. J Cell Physiol 2004;199:89-97.
28. Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC. Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation. Mol Cell Biol 2003;23:9361-74.
29. Sallinen SL, Sallinen PK, Haapasalo HK, et al. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res 2000;60:6617-22.
30. Furuta M, Weil RJ, Vortmeyer AO, et al. Protein patterns and proteins that identify subtypes of glioblastoma multiforme. Oncogene 2004;23:6806-14.
31. von Deimling A, von Ammon K, Schoenfeld D, et al. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 1993;3:19-26.
32. Watanabe K, Tachibana O, Sata K, et al. Over-expression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 1996;6:217-23.
33. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2002;408:307-10.
34. Zhao R, Gish K, Murphy M, et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 2003;14:981-93.
35. Zheng L, Lee WH. Retinoblastoma tumor suppressor and genome stability [review]. Adv Cancer Res 2002;85: 13-50.
36. Henson JW, Schnitker BL, Correa KM, et al. The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 1994;36:714-21.
37. Chang HY, Sneddon JB, Alizadeh AA, et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2004;2:E7.
38. Wang TN, Albo D, Tuszynski GP. Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 production. Surgery 2002; 132:220-5.
39. Morikawa S, Takabe W, Mataki C, et al. The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells. J Atheroscler Thromb 2002;9:178-83.
40. Brat DJ, Van Meir EG. Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest 2004;84:397-405.
41. Tanwar MK, Gilbert MR, Holland EC. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res 2002;62:4364-8.
42. Rickman DS, Bobek MP, Misek DE, et al. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res 2001;61:6885-91.
43. Markert JM, Fuller CM, Gillespie GY, et al. Differential gene expression profiling in human brain tumors. Physiol Genomics 2001;5:21-33.
44. Das R, Mahabeleshwar GH, Kundu GC. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells. J Biol Chem 2004;79:11051-64.
45. Tuck AB, Hota C, Wilson SM, Chambers AF. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways. Oncogene 2003; 22:1198-205.
46. Das R, Mahabeleshwar GH, Kundu GC. Osteopontin stimulates cell motility and nuclear factor κB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells. J Biol Chem 2003; 278:28593-606.
47. Rich JN, Shi Q, Hjelmeland M, et al. Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J Biol Chem 2003;278:15951-7.